Leishmaniasis host response loci (lmr1–3) modify disease severity through a Th1/Th2-independent pathway
Open Access
- 11 December 2003
- journal article
- research article
- Published by Springer Nature in Genes & Immunity
- Vol. 5 (2), 93-100
- https://doi.org/10.1038/sj.gene.6364042
Abstract
The severity of disease caused by infection with Leishmania major depends critically on the genetics of the host. Early induction of T helper (Th)1-type immune responses in the resistant C57BL/6 mice and Th2-type responses in the susceptible BALB/c mice are thought to determine cure or disease, respectively. We have previously mapped three host response loci in a genetic cross between C57BL/6 and BALB/c mice, and here we show definitively the involvement of these loci in disease severity using animals congenic for each of the loci. Surprisingly, in the late stage of infection when the difference in disease severity between congenic and parental mice was most pronounced, their cytokine profile correlated with the genetic background of the mice and not with the severity of disease. This indicates that the loci that we have mapped are acting by a mechanism independent of Th phenotype.Keywords
This publication has 37 references indexed in Scilit:
- Inherited disorders of IL-12- and IFNγ-mediated immunity: a molecular genetics updateMolecular Immunology, 2002
- The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile CureThe Journal of Experimental Medicine, 2001
- Quantification of Murine IFN‐γ mRNA and Protein Expression: Impact of Real‐Time Kinetic RT–PCR Using SYBR Green I DyeScandinavian Journal of Immunology, 2001
- Speed congenics: a classic technique in the fast lane (relatively speaking)Immunology Today, 1997
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Endotoxins in the blood and cerebrospinal fluid of patients with African sleeping sicknessParasitology, 1996
- Multiple Hypothesis TestingAnnual Review of Psychology, 1995
- Interleukin‐4 and interleukin‐10 synergize to inhibit cell‐mediated immunity in vivoEuropean Journal of Immunology, 1993
- GENETIC CONTROL OF LEISHMANIA MAJOR INFECTION IN CONGENIC, RECOMBINANT INBRED AND F2 POPULATIONS OF MICEInternational Journal of Immunogenetics, 1993
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989